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Abstract
Purpose: CheckTomo is an independent dose calculation software for tomotherapy.
Recently, Accuray (Accuray Inc., Sunnyvale, CA, USA) released an upgrade of its
tomotherapy treatment device, called TomoEDGE Dynamic Jaws, which improves
the quality of treatment plans by enhancing the dose delivery with the help of jaws
motion. This study describes the upgrade of CheckTomo to that new feature.
Methods: To account for the varying width and off-axis shift of dynamic jaws ﬁelds,
the calculation engine of CheckTomo multiplies the treatment ﬁeld proﬁle by a
penumbral ﬁlter and shifts the dose calculation grid. Penumbral ﬁlters were obtained
by dividing the edge ﬁeld proﬁles by that of the corresponding nominal ﬁeld. They
were sampled at widths 1.0, 1.8, and 2.5 cm at isocenter in the edges of the 2.5
and 5 cm treatment ﬁeld.
Results: The upgrade of CheckTomo was tested on 30 patient treatments planned
with dynamic jaws. The gamma pass rate averaged over 10 abdomen plans was
95.9%, with tolerances of 3 mm/3%. For 10 head and neck plans, the mean pass
rate was 95.9% for tolerances of 4 mm/4%. Finally, misplacement and overdosage
errors were simulated. In each tested cases, the 2 mm/3% gamma pass rate fell
below 95% when a 4 mm shift or 3% dose difference was applied.
Conclusions: These results are equivalent to what CheckTomo achieves in static
jaws cases. So, in terms of dose calculation accuracy and errors detection, the
upgraded version of CheckTomo is as reliable for dynamic jaws plans as the former
release was for static cases.
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1 | INTRODUCTION
Independent dose veriﬁcation is considered to be important to ensure
patient safety.1 It can be performed through an independent calcula-
tion with commercial softwares for three-dimensional conformal radia-
tion therapy (3DCRT), image-modulated radiation therapy (IMRT), and
volume-modulated arc therapy (VMAT) treatments. For tomotherapy,
as far as we know, there exists a commercial tool, Mobius 3D (Mobius
Medical Systems, Houston, TX, USA), and a single-point dose veriﬁca-
tion software.2 Additionally, an open source solution, CheckTomo,
was released in 2011.3 That software independently generates a
three-dimensional point-based dose distribution, using patient CT
images and delivery plan, and compares it against the dose volume cal-
culated by the tomotherapy treatment planning system (TPS).
Accuray (Accuray Inc., Sunnyvale, CA, USA) released an upgrade
of its tomotherapy device called TomoEDGE Dynamic Jaws.4 The
purpose of this upgrade is to reduce the ﬁeld penumbra along the
patient longitudinal (inferior–superior) axis by the mean of jaws
motion. The way the dose is delivered is hence modiﬁed and the
dose calculation engine of CheckTomo needed to be upgraded
consequently.
This study aims to present the work done to develop and imple-
ment the upgrade of CheckTomo and the tests that were performed
to assess that the dose calculation carried out with the upgrade is as
reliable as it was with the previous version. It does not suggest any
improvement of the core calculation engine.
2 | MATERIALS AND METHODS
2.A | TomoEDGE dynamic jaws
In tomotherapy, the ﬁeld is delimited in the longitudinal (IEC-y)
direction by a pair of collimators, called jaws. A non-TomoEDGE
direct or helical tomotherapy treatment is delivered with static jaws,
i.e., at ﬁxed ﬁeld width during the whole treatment procedure, either
1, 2.5, or 5 cm at isocenter. This implies that the ﬁeld penumbra in
the longitudinal direction is of approximately the ﬁeld size on both
cranial and caudal sides of the target. To limit the extra dose to
organs at risk (OAR) and other healthy tissues, the treatment can be
delivered with a smaller ﬁeld width, but this usually increases the
irradiation time.
To overcome this poor trade-off, TomoEDGE introduced jaws
motion during treatment delivery.5 At treatment start, the jaws deli-
mit at isocenter an asymmetrical 1 cm wide ﬁeld, located off the
source axis toward the patient’s feet. Then as the couch moves for-
ward, the cranial jaw sweeps toward the patient’s head to keep the
ﬁeld edge 5 mm ahead of the planning target volume (PTV), until the
jaws delimit a symmetrical ﬁeld (respectively to the beam axis) of
the nominal treatment size, either 2.5 or 5 cm at isocenter. Similarly,
the caudal jaw closes behind the PTV as it exits the beam, until the
ﬁeld is 1 cm wide again.4 In a TomoEDGE treatment, the penumbra
on the cranial and caudal sides of the PTV is reduced to 1 cm. See
Fig. 1 for a graphical depiction.
For clarity, the ﬁelds will be denominated “nominal” when delim-
ited by symmetrically positioned static jaws and “edge” otherwise.
2.B. | CheckTomo
2.B.1 | Software basics
CheckTomo is a software written in MATLAB (The MathWorks Inc.,
Natick, MA, USA) that computes a three-dimensional point-based
dose distribution using CT data and treatment plan on the patient
side and independently acquired beam data on the machine side.
Patient data are read from DICOM CT and RT-plan ﬁles where
beam geometry and patient position during treatment are described.
Beam data are provided with CheckTomo for each nominal treat-
ment ﬁeld in text ﬁles with a homemade structure. They consist of a
reference dose point, tissue-phantom ratios (TPRs), output factors
(OFs), and off-axis ratios (OARs) measured for various ﬁeld shapes.
The 5 9 40 cm2 ﬁeld at isocenter was taken as the reference one
and the dose reference point was measured isocentrically at depth
10 cm. All machine data were independently acquired on a
tomotherapy unit using an ionization chamber at different depths in
a water tank.
CheckTomo dose distribution is usually calculated on a grid of
15 9 15 9 15 points, with a 1 to 1.5 cm spacing. Grid resolution
and size can be adapted if needed. For each sinogram projection (or
control point), the dose deposited at a particular location is the
F I G . 1 . Schematic representation of a TomoEDGE treatment beam at two moments. Dashed lines represent the nominal ﬁeld width. Edge
ﬁelds (in red) are represented at treatment start (right) and end (left). At treatment start, the jaws delimit a 1 cm wide ﬁeld on the negative
IEC-y side of the beam axis. During treatment (not represented), as the PTV moves forward, the cranial jaw opens to keep the superior ﬁeld
edge ahead of the PTV superior limit. Then, the caudal jaw closes to keep the inferior ﬁeld edge behind the PTV inferior limit. Finally, when
the treatment ends, the jaws delimit a 1 cm wide ﬁeld again, but on the positive IEC-y side of the beam axis.
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product of the projection time, the dose rate, TPR, OF, and OAR.
The ﬂuence is considered to arise from the mean angle of the pro-
jection arc, which, regarding the tomotherapy standard of deﬁning
51 control points per gantry rotation, extends over 7.29°. To
increase the number of control points and thus improve the dose
calculation accuracy, CheckTomo offers the option to split each pro-
jection into multiple subprojections.6
CheckTomo dose distribution can be compared to that calculated
by the tomotherapy treatment planning system (TPS) by means of a
gamma7 or box comparison index.8 Required patient data, beam
data collection, dose calculation model, and comparison indices
were explained in more detail in the original release paper of
CheckTomo.3
2.B.2 | Beam proﬁle model
In CheckTomo, the longitudinal proﬁle of a nominal ﬁeld is calculated
by multiplying the ﬁeld OAR, the TPR, and the OF. CheckTomo han-
dles OARs expressed in angular distance respectively to the beam
source, instead of Cartesian coordinates. It follows the tomotherapy
naming conventions of ﬁeld size, calling the longitudinal dimension
the width and the in-plane dimension the length (width and length
are always given at isocenter). Which is more, the OF of the
tomotherapy beam, hereafter Scp, is not a function of the equivalent
square ﬁeld size but depends independently on both the ﬁeld width
and length.3 In CheckTomo, it is therefore considered to be a func-
tion Scp;w0 of the ﬁeld length speciﬁc to the nominal ﬁeld of width
w0.
Thus, the longitudinal proﬁle at angular coordinate hy and depth
d of a nominal ﬁeld of width w0 and length L is given by
PNðw0; L; hy; dÞ ¼ OARyðhy; dÞ  TPRðAsq; dÞ  Scp;wo ðLÞ: (1)
Asq is the equivalent square ﬁeld size.
2.C. | Implementation of a dynamic jaws beam
proﬁle model in CheckTomo
Jaws motion induces changes in the ﬁeld shape and OF that have to
be accounted for in the proﬁle model. Theoretically, the longitudinal
proﬁle of an edge ﬁeld is obtained by multiplying Eq. (1) by a jaw
penumbral ﬁlter and by correcting the OF. But as mentioned in sec-
tion 2.B.2, the OF function Scp was not designed to account for a
varying ﬁeld width. To overcome this limitation, the relative jaw
penumbral ﬁlter (RJPF) was introduced, deﬁned as the ratio of the
edge and nominal longitudinal proﬁles PE and PN,
RJPFðw;w0; hy; dÞ ¼ PEðw;w0; L; hy; dÞPNðw0; L; hy; dÞ : (2)
Here PE is the edge ﬁeld proﬁle given in angular coordinates
respectively to the beam source. The transformation consists in ﬁrst
applying a coordinates shift along the longitudinal axis so that the
ﬁeld maximum is at IECy = 0. Then, the shifted Cartesian coordi-
nates are converted in angular distances.
The edge ﬁeld proﬁle equation is obtained by inverting rela-
tion (2) and replacing PN with equation (1), namely
PEðw;w0; L; hy; dÞ ¼ OARyðhy; dÞ  TPRðAsq;dÞ  Scp;w0 ðLÞ
 RJPFðw;w0; hy; dÞ:
(3)
Note that it yields a proﬁle originating at the source axis. To
account for the edge ﬁeld off-axis nature, the dose calculation grid is
shifted longitudinally — toward head or feet depending on the edge
side — by half the ﬁeld width.
In practice, PE and PN were sampled at ﬁeld widths and
depths speciﬁed in section 2.D, normalized, respectively, to PN
peak maxima and converted into angular coordinates. RJPFs were
then calculated from Eq. (2) by interpolating PE and PN over for a
set of arbitrary points. These data were stored in new text ﬁles
structured like the existing CheckTomo beam data ﬁles. Note that
the RJPFs were not sampled at different ﬁeld lengths because it
was checked that this parameter only has a slight inﬂuence on
the longitudinal proﬁles. Lastly, for widths and depths falling
between sampling values, the RJPF is interpolated on the ﬂy at
run time.
2.D. | Measurements of edge beam data
Proﬁles measurements were performed with an Exradin A1SL ioniza-
tion chamber (Standard Imaging, Middleton, WI, USA) in a water
tank at SSD 85 cm, all MLC leaves open and depths 1.5, 5, 10, 15,
and 20 cm. They were all run successively for the nominal and edge
ﬁelds.
Measurements of both the edge and nominal proﬁles were
needed to calculate the RJPF from Eq. (2). The edge ﬁeld width
varying continuously between 1 cm and the nominal ﬁeld size, it
was necessary to pick some sampling values. During the TomoEDGE
acceptance test procedure (ATP), ﬁeld data were measured for
widths 1.0, 1.8, and 2.5 cm in both edges of 5 cm nominal ﬁeld. We
decided to perform proﬁle measurements for that same set of val-
ues. Due to the ﬂattening ﬁlter free (FFF) beam of tomotherapy
units, the proﬁle of an edge ﬁeld depends also on its distance to the
source axis. So, similar measurements were performed in the edge of
the 2.5 cm nominal ﬁeld as well. Obviously, it was sufﬁcient to real-
ize them only on one side of the source axis.
2.E. | Dose calculation veriﬁcation and tests of
accuracy
2.E.1 | Gradient check
Five plans were generated using the images of the Cheese Phantom
and the 5.0 cm plans structures set provided with the TomoPhant
IMRT veriﬁcation patient, which is usually available in the tomother-
apy TPS. Three PTVs of 2 cm, 6 cm, and 10 cm were created by
shrinking or extending the original target volume. Plans were calcu-
lated for the 2.5 cm ﬁeld on these three PTVs and for the 5 cm ﬁeld
on the 6 cm and 10 cm PTVs. All plans were calculated in dynamic
jaw mode. The PTVs were centered on the machine isocenter, the
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prescription dose was of 2 Gy and the pitch was 0.287. To force
some ﬁeld modulation, a constraint was applied on a structure of the
same size as the target located 2 cm beneath it.
All ﬁve plans were calculated in CheckTomo with a 2.5 mm lon-
gitudinal spacing and global 2 mm/3% and 3 mm/4% gamma indices
were calculated. Additionally, the dose proﬁles along the longitudinal
axis in the isocenter plane were extracted from both the CheckTomo
and tomotherapy TPS dose volume so that they could be compared
visually.
2.E.2 | Dose veriﬁcation in real patient cases
The upgrade of CheckTomo was tested on 30 patient cases planned
and treated with dynamic jaws. All plans had successfully passed a
clinical quality assurance (QA) test which consisted in comparing the
TPS dose distribution to a measurement performed with an Octavius
729 detector array in an Octavius II phantom (PTW, Freiburg,
Germany). Dose comparison was done in VeriSoft (PTW, Freiburg,
Germany) using a 3 mm/3% gamma comparison index7 for points
within the 10% isodose and considering a 95% pass rate threshold.
The independent calculation of the dose distributions was per-
formed with the upgraded version of CheckTomo using the original
patients CT images, a 31 9 31 9 31 calculation grid with a longitu-
dinal spacing of 6 mm (8 mm in two cases) and one subprojection
per projection. These grid settings ensured us to cover in each case
a major part of the PTV and to get a reasonably high dose point res-
olution in the ﬁeld edges. Note that in some cases, the PTV was too
large to ﬁt entirely in the dose calculation grid. PTV length and ﬁeld
width for each patient are given in Tables 2–4.
The calculation accuracy was assessed for each of the 30 plans
by computing the mean dose difference and performing global
gamma comparison tests between the CheckTomo and the
tomotherapy TPS dose distributions. The gamma index was calcu-
lated for various tolerances over the points located within the 50%
isodose and at least 5 mm deep in the patient’s body. A test is con-
sidered successful if its gamma pass rate is above 95%.
2.E.3 | Errors simulation
Finally, in order to test the ability of the upgrade of CheckTomo to
detect errors, 15 cases that had passed a 2 mm/3% gamma compar-
ison test were selected, independently of the treatment location.
Then longitudinal misplacements and overdosages were simulated
over them by applying a 2 mm and 4 mm coordinate shift and a 3%
dose offset to the TPS dose distribution.
3 | RESULTS AND DISCUSSION
3.1 | Edge beam data and proﬁles model
Figure 2 shows ﬁeld proﬁles measured and calculated on the positive
IEC-y side of the gantry. All proﬁles were normalized to the maxi-
mum of the corresponding nominal ﬁeld. The difference in relative
intensity between a proﬁle in the edge of the 2.5 cm and 5 cm nom-
inal ﬁeld is visible, particularly for the 1 cm ﬁeld.
Note that Eq. (3) yields a symmetric approximation of the edge
ﬁeld proﬁles, which are actually asymmetric (because the position of
the jaws compared to the axis of the beam generates asymmetric
penumbra). This approximation is inherent to the beam model of
CheckTomo, which was not designed to handle asymmetric ﬁelds.
Though, as can be seen in Fig. 2, the calculated edge proﬁles (plain
TAB L E 1 Gamma pass rate (c) for two tolerances and average
mean dose difference (DD) of the ﬁve plans calculated in the
TomoPhant. Points within the 50% isodose and at least 5 mm depth
were considered in the calculation of the gamma index.
Field
width [cm]
PTV
length [cm]
c 2 mm,
3% [%]
c 3 mm,
4% [%] DD [%]
2.5 2 91.2 96.4 2.2
2.5 6 100.0 100.0 0.0
2.5 10 99.8 100.0 1.0
5.0 6 88.0 96.0 0.1
5.0 10 86.7 95.3 0.9
TAB L E 2 Geometrical setup, gamma pass rate (c) for various tolerances and average mean dose difference (DD) of the 10 abdomen plans.
Points within the 50% isodose and at least 5 mm depth were considered in the calculation of the gamma index.
Case PTV dose [Gy] Field width [cm] PTV length [cm] c 2 mm, 3% [%] c 3 mm, 3% [%] c 4 mm, 4% [%] DD [%]
A01 2 5.054 30.2 97.8 99.2 100.0 0.9
A02 1.8 2.51 29.2 83.7 88.6 96.4 1.8
A03 2 2.51 9.75 100.0 100.0 100.0 0.27
A04 1.8 2.51 17.6 97.0 98.2 99.2 0.5
A05 7 2.51 3.8 97.5 99.1 100.0 1.93
A06 1.8 5.054 20.4 84.2 89.6 94.5 1.38
A07 2 2.51 13 99.5 99.8 100.0 0.2
A08 2 2.51 12.2 83.6 85.8 93.0 2.56
A09 3 2.51 19.2 97.9 98.6 99.7 0.8
A10 2.3 2.51 33.4 99.6 99.9 100.0 0.7
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lines) show a good agreement with the measurements (dots). The
maximal error induced by the approximation of Eq. (3) is of respec-
tively 2.7% and 1.5% for the 1 cm and 2.5 cm edge ﬁelds. Also note
that in Eq. (3), the spatial coordinate is the angular distance at the
source, but that the ﬁeld proﬁles are represented in Fig. 2 in Carte-
sian coordinates.
Figure 3 shows the relative jaw penumbral ﬁlters of the 2.5 cm
and 5 cm nominal ﬁeld, deﬁned by Eq. (2) and calculated using the
measured proﬁles shown in Fig. 2. One can see that the RJPFs are
depth-dependent, as are the ﬁeld proﬁles. Also, one should note
that they do not converge toward 0 when reaching the ﬁeld limit,
as would be expected. This is a numerical artifact: obviously, both
the nominal and edge ﬁeld proﬁles also tend toward 0 at the ﬁeld
boundary, and dividing two small values one with another [in
Eq. (2)] may result in large numbers. In other words, the RFJPs are
hardly calculable outside the ﬁeld. Though, this is not an issue
because the product of the proﬁle and the RJPF [in Eq. (3)] con-
verges toward 0 at the ﬁeld limit. As can be seen on Fig. 2, the
calculated edge ﬁeld proﬁles (plain lines) match the measurements
(dotted lines).
Finally, CheckTomo upgrade was designed having in mind that
TomoEDGE could in the future evolve and perform more complex
dose sculpting. One can think of sharpening the edges of a simulta-
neous integrated boost (SIB) or tracking a tumor.
TAB L E 5 Number of successes to the gamma comparison test
(Nc>95%, i.e., pass rate above 95%) and mean gamma pass rate (c) for
various tolerances for the three different regions investigated. Ten
treatment plans were tested in each region. Points within the 50%
isodose and at least 5 mm depth were considered in the calculation
of the gamma index.
Abdomen and
pelvis Head and neck Breast
Nc>95% c [%] Nc>95% c [%] Nc>95% c [%]
2 mm, 3% 7 94.1 3 86.8 4 88.7
2 mm, 4% 7 97.2 7 93.1 5 92.3
3 mm, 3% 7 95.9 4 90.3 5 93.5
3 mm, 4% 8 97.9 7 95.0 8 94.9
3 mm, 5% 10 98.9 7 97.5 9 98.0
3 mm, 6% 10 99.4 10 98.5 10 98.9
4 mm, 4% 8 98.3 7 95.9 8 97.1
DD [%] 1.1 1.8 1.8
TAB L E 3 Geometrical setup, gamma pass rate (c) for various tolerances and average mean dose difference (DD) of the 10 head and neck
plans. Points within the 50% isodose and at least 5 mm depth were considered in the calculation of the gamma index.
Case PTV dose [Gy] Field width [cm] PTV length [cm] c 2 mm, 3% [%] c 3 mm, 3% [%] c 4 mm, 4% [%] DD [%]
HN01 2 2.51 12.75 69.2 74.6 88.9 3.7
HN02 2.12 2.51 7.75 65.6 76.6 89.6 3.1
HN03 2.12 2.51 14.75 100.0 100.0 100.0 0.3
HN04 2.12 2.51 15 88.1 91.8 97.9 2.3
HN05 2 2.51 12.4 90.0 92.5 97.5 2.2
HN06 2.12 2.51 15.6 93.5 96.1 98.5 1.6
HN07 2 2.51 13.8 92.3 93.3 96.8 0.9
HN08 2 2.51 11.2 75.0 82.0 90.6 3.0
HN09 2.12 2.51 16 95.2 96.7 99.0 0.8
HN10 2.12 2.51 18.75 99.2 99.3 100.0 0.1
TAB L E 4 Geometrical setup, gamma pass rate (c) for various tolerances and average mean dose difference (DD) of the 10 breast plans. Points
within the 50% isodose and at least 5 mm depth were considered in the calculation of the gamma index.
Case PTV dose [Gy] Field width [cm] PTV length [cm] c 2 mm, 3% [%] c 3 mm, 3% [%] c 4 mm, 4% [%] DD [%]
B01 2 2.51 23.6 91.5 95.2 98.2 2.0
B02 2 2.51 14.4 73.4 81.8 91.5 2.8
B03 2 2.51 21.8 87.4 92.6 96.8 2.0
B04 1.8 2.51 21.4 98.1 99.1 99.7 1.3
B05 2 2.51 25.4 95.8 97.0 99.7 1.5
B06 2 2.51 24.6 98.2 98.8 99.7 0.5
B07 2 2.51 20.6 90.2 93.7 97.8 2.0
B08 2 2.51 20.4 85.1 91.0 96.5 2.4
B09 2 2.51 23.8 96.3 97.3 99.3 1.1
B10 2.65 2.51 20.2 71.1 88.2 91.7 2.8
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3.B | Dose calculation gamma pass rate
3.B.1 | Gradient veriﬁcation
Gamma index pass rates for all ﬁve plans calculated in the Tomo-
Phant are given in Table 1. With the 2.5 cm ﬁeld, the pass rate is
high (99.8%) for the 6 cm and 10 cm target. For the 2 cm target,
the index tolerance must be increased to 3 mm/4%. Note that this
case was designed for testing purposes. In clinical practice, it would
not make sense to try to cover a 2 cm long PTV with the 2.5 cm
wide ﬁeld and the 1 cm ﬁeld would have been used instead.
The gamma pass rates of the plans calculated with the 5 cm ﬁeld
are lower, below 90% for the 2 mm/3% tolerance. As can be seen in
Fig. 4 (b), the dose calculation is perturbed over 5 cm by the approx-
imation of the varying ﬁeld width proﬁle. Though, this ﬁgure also
shows that calculation of the ﬁeld gradient by CheckTomo matches
well that of the TPS both in space and dose.
3.B.2 | Real patient cases and errors detection
The calculation of 29,791 dose points for one case takes between 2
and 3 minutes on Intel Core i5 3.4 GHz processor, depending on the
size of the region of interest considered.
CheckTomo was tested on 10 abdomen and pelvis, 10 head and
neck (H&N), and 10 breast plans. For each case, the mean dose dif-
ference (DD) and global gamma comparison tests between the
CheckTomo and the tomotherapy TPS dose distributions were calcu-
lated. Individual results of all cases are provided in Tables 2–4. For
each location and tolerances, the number of plans that succeed the
gamma test (Nc>95%, i.e., pass rate above 95%) and the mean gamma
pass rate (c) over the 10 plans are given in Table 5. One can see that
plans in the abdominal and pelvic region are the most accurately cal-
culated with at least 7 plans out of 10 succeeding the gamma com-
parison test. In the opposite, dose calculation for the H&N cases is
F I G . 3 . Relative jaw penumbral ﬁlters of
the 2.5 cm (a) and 5 cm (b) nominal ﬁelds
for each of the three off-axis edge ﬁeld
widths sampled, along the machine
longitudinal (IEC-y) axis. RJPF are shown at
depth 1.5 cm (solid lines) and 10 cm
(dashed lines).
F I G . 4 . Dose proﬁles of the plans
calculated in the TomoPhant for varying
PTV length, for the 2.5 cm ﬁeld width (a)
and 5 cm (b). Plain line corresponds to the
dose calculated by the tomotherapy TPS
and dots to CheckTomo dose points.
F I G . 2 . Longitudinal proﬁles, along the machine IEC-y axis, of the 2.5 cm (a) and 5 cm (b) on-axis nominal ﬁelds (black) and their related off-
axis edge ﬁelds (colored). Dots represent measurements, plain lines the edge proﬁles calculated from Eq. (3). Measurements were performed at
1.5 cm depth, all leaves open, on the positive IEC-y side of the gantry. Values in the legend correspond to the ﬁeld width at isocenter.
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more prone to errors and requires the gamma index dose tolerance
to be increased to 4% to have a majority of plans succeeding the
test. This can be explained by the fact that PTVs in the abdominal
and the pelvic area usually encompass large homogenous tissue vol-
umes, while bones and air cavities can be found in the H&N region.
The difference of calculation accuracy between those two kinds of
location comes from the fact that the dose calculation in CheckTomo
relies on a water-based model, which is obviously more reliable in
tissues with densities close to water. Note that the scope of this
manuscript is to describe the implementation of TomoEDGE in
CheckTomo, not to suggest improvements of its calculation engine.
Concerning the breast cases, where the target volumes are often
off-axis, increasing the number of subprojections per projection from
1 to 3 or 5 could improve the results accuracy.6
Table 6 shows the results of the error simulation tests. It con-
cerns 15 cases that had passed the 2 mm/3% gamma comparison
test. As one can see, all plans failed the 2 mm/3% gamma test when
a 4 mm shift was applied longitudinally to the calculation grid or if
the dose was offset by 3%.
The results of the gamma comparison tests presented here for
dynamic cases are similar to what had been obtained for static jaws
plans with the original release of CheckTomo.3 In other words, the
overall dose calculation accuracy and sensitivity to errors is equiva-
lent for both TomoEDGE and non-TomoEDGE plans.
Performing an independent dose calculation with CheckTomo is
not as comprehensive as actually measuring it during a QA proce-
dure, in that sense that it performs no control on the machine side.
Though, CheckTomo successfully detected simulated errors exceed-
ing tolerances. In other words, it is conservative of the quality assur-
ance, thus can provide a good indicator of the accuracy of the dose
calculation. Nonetheless, the way CheckTomo could be used in
practice (e.g., replace a patient QA measurements) remains the
responsibility of the local medical physicist.
3.C | Occasional edge dose calculation error
In some cases, the dose is over or under estimated in the target vol-
ume edges, as shown in Fig. 5 left-hand side. The occurrence of
such errors seems random and is caused by rounding mistakes in the
calculation of the dose grid coordinates. Even a submillimetric regis-
tration error between the CheckTomo and tomotherapy TPS dose
distributions could lead to a dose miscalculation of several Gy within
the high gradient region. Though, such a problem can be easily
addressed by shifting longitudinally the TPS dose volume, using a
manual registration tool included in CheckTomo since the ﬁrst ver-
sion. As it happens, the error appearing in Fig. 5 was corrected by
applying a 1 mm shift. The result is shown on the ﬁgure right-hand
side.
Even if such an error is not accounted for, it does not much
impact the overall gamma pass rate of the plan (0.3% in the case of
Fig. 5). The relative dose difference does usually not exceed 10%
and concerns only the points located in the ﬁeld edges, hence a
small portion of the PTV. However, one should note that Check-
Tomo was not speciﬁcally designed to be a dose gradient veriﬁcation
tool and should not try to use it as such. CheckTomo cannot isolate
a particular region of interest and lacks analysis tools dedicated to
conformality veriﬁcation.9
4 | CONCLUSION
CheckTomo software for independent dose calculation in tomother-
apy was upgraded for TomoEDGE treatments by introducing the
RPJF in its proﬁle calculation model. It was noted that this method
implies that a slight inaccuracy in the edge ﬁeld proﬁles calculation
has to be tolerated. The results of the gamma comparison tests
demonstrated that, in terms of dose calculation accuracy and errors
detection, the upgraded version of CheckTomo is as reliable for
dynamic jaws plans as the former release was for static cases. This
leads us to conclude that, from now on, CheckTomo offers the
opportunity to perform independent dose calculation equivalently
for both static and dynamic jaws tomotherapy plans.
TAB L E 6 Number of cases succeeding the gamma test (Nc>95%),
mean pass rate (c), and average mean dose difference (DD) for 15
treatment plans on which was applied a longitudinal shift of 2 and 4
mm and a dose offset of 3%. Only plans which had passed (without
simulated error) a 2 mm/3% gamma test were considered.
Unshifted 2 mm shift 4 mm shift Overdosage 3 %
Nc>95% [%] 15 13 0 0
c [%] 98 96.7 83.7 63.2
DD [%] 0.79 0.77 0.91 3.49
F I G . 5 . Coronal view of the relative
difference, given in percent, between the
CheckTomo and the tomotherapy TPS
dose of a pelvis plan. As one can see in
ﬁgure (a), the dose is miscalculated in both
edges of the target volume. The error is
corrected by applying a 1 mm shift in the
longitudinal direction (IEC-y) to the TPS
dose distribution, as shown in ﬁgure (b).
98 | SCHOPFER ET AL.
CONFLICT OF INTEREST
R. Moeckli is holding a grant from Accuray for a research project in
tomotherapy. However, the present work is not directly related to
that grant.
REFERENCES
1. IAEA. Technical Reports Series No. 430 : Commissioning and Quality
Assurance of Computerized Planning Systems for Radiation Treatment of
Cancer; 2004.
2. Gibbons JP, Smith K, Cheek D, Rosen I. Independent calculation of dose
from a helical TomoTherapy unit. J Appl Clin Med Phys. 2009;10:2772.
3. Thomas SJ, Eyre KR, Tudor GSJ, Fairfoul J. Dose calculation software
for helical tomotherapy, utilizing patient CT data to calculate an inde-
pendent three-dimensional dose cube. Med Phys. 2012;39:160–167.
4. Accuray Inc. Physics training on the TomoEDGE feature ETT.700064.D;
2013.
5. Katayama S, Haefner MF, Mohr A, et al. Accelerated tomotherapy
delivery with TomoEdge technique. J Appl Clin Med Phys.
2015;16:4964.
6. Tudor GSJ, Thomas SJ. Impact of the ﬁxed gantry angle approxima-
tion on dosimetric accuracy for helical tomotherapy plans. Med Phys.
2013;40:011711.
7. Low DA, Harms WB, Mutic S, Purdy JA. A technique for the
quantitative evaluation of dose distributions. Med Phys. 1998;25:656–
661.
8. Thomas SJ, Cowley IR. A comparison of four indices for combining
distance and dose differences. Int J Radiat Oncol Biol Phys. 2012;82:
e717–e723.
9. Feuvret L, No€el G, Mazeron J-J, Bey P. Conformity index: a review.
Int J Radiat Oncol Biol Phys. 2006;64:333–342.
SCHOPFER ET AL. | 99
